Amneal’s Generics Business Reinvigorated By New Launches

Company Eyes China As A ‘Massive Market’ For Its Generics

ladder
Amneal made 29 new ANDA filings in 2020 and expects to file 30 products in 2021 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business